XIFIN has been a leader in Molecular Diagnostics by helping the country’s largest molecular testing laboratories meet their most complex reimbursement challenges.
A proven leader in the Molecular testing market, XIFIN processes over half of all claims submitted by laboratories specializing in molecular testing laboratories nationwide, including those from leading companies like; Myriad, US Labs/Esoterix, Clarient, and others.
- We Help You Stay In Front Of Change – Along with rapid growth and the increasingly complex reimbursement issues that inevitably follows, XIFIN has been helping businesses face these challenges head on. Whether it is managing the typical reimbursement challenges faced by all laboratories, or addressing long standing difficulties such as modifier and consolidation rules, new payor requirements and split jurisdiction issues, we’ve been on the forefront of solving these problems and have designed the XIFIN billing system to quickly adjust to the needs of our clients.
- We Help You Adjust To Rapid Growth - Molecular testing capabilities have delivered hyper-growth to many laboratories, leaving these business's billing operations overwhelmed by the depth and breadth of the claims volume. XIFIN’s billing system helps high-growth laboratories address this issue by utilizing a sophisticated rules-based workflow to automate the claims process, thus requiring very little manual intervention, enabling laboratories to more easily scale their billing operations to match their rapid growth.
- Solutions Specifically For Early Stage Molecular Laboratories – As a response to the unique challenges faced by early stage molecular laboratories, XIFIN has developed a unique hybrid outsourcing solution that is designed to grow with your laboratory. With XIFIN, early stage molecular laboratories have the ability to seamlessly adjust the level of control they want over their billing process: from completely outsourcing everything to managing a fully staffed, in-house billing department.
- Consulting Services for Commercialization and Reimbursement Strategies – To successfully bring your new Molecular Diagnostics Concept to market, there are many things to consider well in advance of any decisions regarding your billing and Accounts Receivable solution. XIFIN provides early stage companies expert professional services to guide them through the complex process of commercialization that can lead to successful reimbursement strategies. XIFIN’s consulting service, led by Rina Wolf, XIFIN's Vice President of Strategic Commercialization, Consulting, And Industry Affairs will help you gain insights into important critical success factors such as;
- Clinical Utility / Medical Efficacy / Outcomes
- Patient Advocacy Programs
- Removing Reimbursement Barriers to Early Test Adoption
- Coding and Pricing Strategies
- Regulatory and Legislative Environment
Designed around industry best practices, and used to process more than 150 million claims for most of the nations’ largest laboratories, XIFIN has proven to an important partner in enabling laboratories to automate their billing systems, better manage medical claims filing, and reduce the costs associated with regulatory compliance.